✦ LIBER ✦

W1268 The Course of Infliximab Discontinuation After Long-Term Maintenance Treatment in Crohn's Disease

✍ Scribed by Armuzzi, Alessandro; Rizzi, Marina; Monterubbianesi, Rita; Marzo, Manuela; Cicala, Michele; Guidi, Luisa; Prantera, Cosimo; Kohn, Anna

Book ID: 122837830
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 184 KB
Volume: 138
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(10)63159-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.91 THE COURSE OF INFLIXIMAB DISCONTINU

P.91 THE COURSE OF INFLIXIMAB DISCONTINUATION AFTER LONG-TERM MAINTENANCE THERAPY IN CROHN'S DISEASE

✍ A. Armuzzi; M. Rizzi; R. Monterubbianesi; M. Marzo; M. Cicala; L. Guidi; C. Pran 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 85 KB

W1260 Maintenance of Clinical Benefit in

W1260 Maintenance of Clinical Benefit in Crohn's Disease Patients After Discontinuation of Infliximab: Long Term Follow-up of a Single Center Cohort

✍ Waugh, Alistair W.; Wong, Karen; Fedorak, Richard N. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Maintenance of clinical benefit in Crohn

Maintenance of clinical benefit in Crohn’s disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort

✍ A. W. G. Waugh; S. Garg; K. Matic; L. Gramlich; C. Wong; D. C. Sadowski; M. Mill 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Long-term outcome of maintenance inflixi

Long-term outcome of maintenance infliximab therapy in children with Crohn's disease

✍ Jeffrey S. Hyams; Trudy Lerer; Anne Griffiths; Marian Pfefferkorn; Subra Kugatha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 2 views

Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i

Factors influencing long-term outcome of

Factors influencing long-term outcome of infliximab treatment in Crohn's disease

✍ Sachdev, Ritu; Banks, Peter A.; Wolf, Jacqueline L.; Strate, Lisa L.; Friedman, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Impact of prior irregular infliximab dos

Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease

✍ Daniel J. Stein; Ashwin N. Ananthakrishnan; Mazen Issa; John B. Williams; Dawn B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB 👁 2 views

## Background: Infliximab is efficacious in the management of moderate to severe crohn's disease (cd). there are limited data regarding performance of infliximab in patients who require reinitiation of maintenance dosing following previous irregular exposure. ## Methods: This was a retrospective,